RB1 and neoplasm: We first conducted IHC for total Rb1 expression to exclude the loss of Rb1, and we observed that Rb1- negative tumor cells accounted for less than 5% of all tumor cells in tumors from each of the four genotypes, which is consistent with previously published reports [43].